310 related articles for article (PubMed ID: 12218418)
1. The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects.
Kruuse C; Thomsen LL; Jacobsen TB; Olesen J
J Cereb Blood Flow Metab; 2002 Sep; 22(9):1124-31. PubMed ID: 12218418
[TBL] [Abstract][Full Text] [Related]
2. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter.
Kruuse C; Thomsen LL; Birk S; Olesen J
Brain; 2003 Jan; 126(Pt 1):241-7. PubMed ID: 12477710
[TBL] [Abstract][Full Text] [Related]
3. The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow.
Birk S; Kruuse C; Petersen KA; Jonassen O; Tfelt-Hansen P; Olesen J
J Cereb Blood Flow Metab; 2004 Dec; 24(12):1352-8. PubMed ID: 15625409
[TBL] [Abstract][Full Text] [Related]
4. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
[TBL] [Abstract][Full Text] [Related]
5. Dipyridamole dilates large cerebral arteries concomitant to headache induction in healthy subjects.
Kruuse C; Jacobsen TB; Lassen LH; Thomsen LL; Hasselbalch SG; Dige-Petersen H; Olesen J
J Cereb Blood Flow Metab; 2000 Sep; 20(9):1372-9. PubMed ID: 10994859
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil increases cerebrovascular reactivity: a transcranial Doppler study.
Brenner S
Neurology; 2006 May; 66(9):1455-6; author reply 1455-6. PubMed ID: 16682690
[No Abstract] [Full Text] [Related]
7. The effects of sildenafil on ocular blood flow.
Koksal M; Ozdemir H; Kargi S; Yesilli C; Tomaç S; Mahmutyazicioglu K; Mungan A
Acta Ophthalmol Scand; 2005 Jun; 83(3):355-9. PubMed ID: 15948790
[TBL] [Abstract][Full Text] [Related]
8. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
Webb DJ; Freestone S; Allen MJ; Muirhead GJ
Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
[TBL] [Abstract][Full Text] [Related]
10. Cerebral haemodynamic response or excitability is not affected by sildenafil.
Kruuse C; Hansen AE; Larsson HB; Lauritzen M; Rostrup E
J Cereb Blood Flow Metab; 2009 Apr; 29(4):830-9. PubMed ID: 19209179
[TBL] [Abstract][Full Text] [Related]
11. Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans.
Borlaug BA; Melenovsky V; Marhin T; Fitzgerald P; Kass DA
Circulation; 2005 Oct; 112(17):2642-9. PubMed ID: 16246964
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil: emerging cardiovascular indications.
Raja SG; Nayak SH
Ann Thorac Surg; 2004 Oct; 78(4):1496-506. PubMed ID: 15464535
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
14. The cholinomimetic agent carbachol induces headache in healthy subjects.
Schytz HW; Wienecke T; Oturai PS; Olesen J; Ashina M
Cephalalgia; 2009 Feb; 29(2):258-68. PubMed ID: 19143771
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers.
Hansen JM; Sitarz J; Birk S; Rahmann AM; Oturai PS; Fahrenkrug J; Olesen J; Ashina M
Cephalalgia; 2006 Aug; 26(8):992-1003. PubMed ID: 16886936
[TBL] [Abstract][Full Text] [Related]
16. Sildenafil improves dynamic vascular function in the brain: studies in patients with pulmonary hypertension.
Rosengarten B; Schermuly RT; Voswinckel R; Kohstall MG; Olschewski H; Weissmann N; Seeger W; Kaps M; Grimminger F; Ghofrani HA
Cerebrovasc Dis; 2006; 21(3):194-200. PubMed ID: 16388195
[TBL] [Abstract][Full Text] [Related]
17. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
Ghofrani HA; Voswinckel R; Reichenberger F; Olschewski H; Haredza P; Karadaş B; Schermuly RT; Weissmann N; Seeger W; Grimminger F
J Am Coll Cardiol; 2004 Oct; 44(7):1488-96. PubMed ID: 15464333
[TBL] [Abstract][Full Text] [Related]
18. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.
Dunkern TR; Hatzelmann A
Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064
[TBL] [Abstract][Full Text] [Related]
19. The effect of propranolol on glyceryltrinitrate-induced headache and arterial response.
Tvedskov JF; Thomsen LL; Thomsen LL; Iversen HK; Williams P; Gibson A; Jenkins K; Peck R; Olesen J
Cephalalgia; 2004 Dec; 24(12):1076-87. PubMed ID: 15566422
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of cAMP, cGMP and CGRP in sildenafil-induced headache.
Kruuse C; Frandsen E; Schifter S; Thomsen LL; Birk S; Olesen J
Cephalalgia; 2004 Jul; 24(7):547-53. PubMed ID: 15196297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
